Corporate Development Analyst Jobs
Corporate Development Analyst jobs are open across financial services, healthcare, technology, and industrials, from entry-level to senior analyst, with common specializations in M&A, strategic partnerships, and portfolio integration. Find a role that fits from the openings below and apply directly.
Find JobsLooking for remote work? View remote corporate development analyst jobs →Overview
Showing 5 of 311+ Corporate Development Analyst jobs
Harrison Hayes | Life Sciences Investment Banking & Strategic Advisory
New York / Hybrid / Remote
Harrison Hayes is looking for an unusually resourceful AI Corporate Development Extern/Intern to work directly with senior leadership at the intersection of artificial intelligence, biotechnology, pharmaceutical strategy, investment banking and corporate development.
This is not a conventional internship.
The assignment is deceptively simple:
Use AI to find valuable life-sciences opportunities before everyone else finds them.
Harrison Hayes is a specialized life-sciences investment banking and strategic advisory firm with experience across M&A, licensing, strategic advisory, capital formation, royalty monetization and transaction-related diligence. The firm has advised on more than $25 billion in life-sciences transactions.
We are developing a new AI-enabled approach to opportunity identification and corporate development. We want someone smart, skeptical and slightly obsessive to help us build it.
What You'll Do
You will use ChatGPT, Claude, Perplexity and other AI and research tools to continuously interrogate the pharmaceutical, biotechnology, medical-device and digital-health landscape.
Your work may include:
Identifying deprioritized, discontinued, non-core and capital-stranded therapeutic assets
Finding clinical programs where a failed endpoint may conceal a different development opportunity
Tracking pipeline restructurings, layoffs, strategic reviews and portfolio-prioritization decisions
Identifying assets available for licensing, divestiture or alternative financing
Finding returned rights following terminated pharmaceutical partnerships
Monitoring clinical-trial results, FDA and EMA developments, SEC filings, earnings calls and scientific publications
Identifying biotechnology companies approaching critical financing or strategic inflection points
Researching potential acquisition, licensing, Build-to-Buy and asset-separation opportunities
Mapping potential buyers, sellers, licensors, licensees and strategic partners
Identifying the executives actually responsible for each opportunity
Verifying contact information and building highly targeted outreach
Developing concise investment theses explaining why Harrison Hayes should investigate an opportunity now
Using AI to uncover connections between scientific evidence, corporate strategy, capital constraints and transaction potential that may not be obvious from conventional screening
You will not simply create lists.
You will be expected to answer the harder question:
Why is this an opportunity?
The Work Gets Interesting Quickly
A biotech company announces that it is discontinuing a Phase II program.
Most people record that the drug failed.
We want you to ask:
Did the drug fail, or did the trial fail?
Was the endpoint wrong? Was the population too broad? Is there a responder phenotype buried in the data? Did the program simply fail to clear the company's internal capital-allocation hurdle? Is the underlying biology still credible? Could another indication work? Could the asset be separated from the company? Would another owner develop it differently? What additional experiment would materially change its value?
Those questions can lead to very different conclusions.
Sometimes the answer will be do nothing.
Sometimes it may be license it, acquire it, reposition it, finance it, separate it or build a new company around it.
Finding that distinction is the job.
AI Is the Tool. Judgment Is the Skill.
We are not looking for someone who describes themselves as an “AI expert” because they know how to prompt ChatGPT.
We want someone who understands that AI can be wrong.
You should know how to push beyond the first answer, interrogate primary sources, cross-reference SEC filings and clinical-trial databases, find contradictory evidence, distinguish published facts from inference and recognize when an apparently exciting opportunity falls apart under scrutiny.
A hallucinated executive, invented email address or nonexistent clinical program isn't research. It is a mistake.
We want someone who understands the difference.
Who We're Looking For
Your academic background could be biotechnology, biology, medicine, pharmacology, finance, economics, business, data science or something less obvious.
Graduate students, MBA candidates, medical students and advanced undergraduates are all potentially interesting.
More important is how you think.
You should be intensely curious about science and business simultaneously. You should enjoy discovering obscure information, connecting unrelated facts and pursuing questions that don't have obvious answers.
If you see:
“Company reduces workforce 40% and prioritizes three clinical programs”
your immediate reaction should be:
“What happened to everything else?”
If you read:
“Phase II trial misses primary endpoint but demonstrates statistically significant activity in a prespecified subgroup”
you should want to know:
“Which subgroup, why, and does anyone else care?”
If a pharmaceutical company returns the rights to an asset after spending $100 million developing it, you should wonder:
“What do they know, what does the biotech know, and what might everybody be overlooking?”
That's the mentality we're looking for.
You Will Work With Real Opportunities
This is not an academic exercise.
Interesting findings can move directly into Harrison Hayes' corporate-development process and potentially become strategic advisory, licensing, M&A or principal-investment opportunities.
Harrison Hayes already operates across asset identification, screening, licensing, M&A, strategic advisory, commercial diligence and portfolio strategy.
The extern/intern will help us explore how far AI can extend that capability.
The larger question behind the position is:
Can we build an intelligence system that identifies scientific and transactional opportunities before they become conventional investment-banking opportunities?
We think we can.
We're looking for someone who wants to help prove it.
To Apply
Send your résumé along with a brief note explaining how you use AI for serious research.
But there is a better way to get our attention.
Find us an opportunity.
Identify one pharmaceutical, biotechnology, medical-device or digital-health asset that you believe Harrison Hayes should be looking at right now.
Tell us what happened, why the obvious interpretation may be incomplete, who owns the asset, what you would investigate next, and why there might be a transaction hiding inside the situation.
Keep it to one page.
If it's something we haven't already found, you'll have our attention. Summary
We are seeking a motivated and dynamic AI Corporate Development Extern / Intern to join our innovative team. This role offers a unique opportunity to gain hands-on experience in strategic corporate initiatives, mergers and acquisitions, financial analysis, and stakeholder management within the fast-evolving artificial intelligence industry. As an integral part of our corporate development efforts, you will contribute to evaluating potential growth opportunities, supporting transaction processes, and assisting with strategic planning activities. This paid internship is designed for individuals eager to develop their expertise in finance, strategic management, and AI-driven business expansion while working alongside seasoned professionals.
Responsibilities
- Assist in conducting quantitative financial analysis and valuation modeling to evaluate potential mergers, acquisitions, or strategic partnerships.
- Support the development of financial projection models and cash flow analyses to inform decision-making processes.
- Contribute to due diligence activities related to M&A transactions, including reviewing financial statements and preparing reports.
- Participate in stakeholder management by preparing presentations and communicating insights effectively with executive teams.
- Aid in strategic planning initiatives by analyzing market trends, competitive landscapes, and industry benchmarks.
- Collaborate with cross-functional teams on project management tasks related to corporate finance activities.
- Help prepare documentation for internal audits, technical accounting reviews, and compliance requirements.
Skills
- Strong foundation in financial statement preparation, accounting principles (GAAP), and technical accounting concepts.
- Proficiency in financial modeling, valuation modeling, and developing financial projection models.
- Experience with M&A financial due diligence, investment banking processes, and private equity transactions.
- Excellent verbal communication skills for presenting complex analyses clearly to executives and stakeholders.
- Ability to manage multiple projects efficiently with strong organizational and project management skills.
- Knowledge of financial software tools and presentation software such as PowerPoint or similar platforms.
- Demonstrated understanding of corporate finance concepts including budgeting, forecasting, cash flow analysis, and internal audits.
- Familiarity with quantitative analysis techniques used in equity research and strategic management contexts.
This internship provides an exceptional platform for aspiring finance professionals interested in AI-driven corporate growth strategies. Join us to develop your skills in a fast-paced environment where innovation meets strategic execution!
Work Location: Remote
Harrison Hayes | Life Sciences Investment Banking & Strategic Advisory
New York / Hybrid / Remote
Harrison Hayes is looking for an unusually resourceful AI Corporate Development Extern/Intern to work directly with senior leadership at the intersection of artificial intelligence, biotechnology, pharmaceutical strategy, investment banking and corporate development.
This is not a conventional internship.
The assignment is deceptively simple:
Use AI to find valuable life-sciences opportunities before everyone else finds them.
Harrison Hayes is a specialized life-sciences investment banking and strategic advisory firm with experience across M&A, licensing, strategic advisory, capital formation, royalty monetization and transaction-related diligence. The firm has advised on more than $25 billion in life-sciences transactions.
We are developing a new AI-enabled approach to opportunity identification and corporate development. We want someone smart, skeptical and slightly obsessive to help us build it.
What You'll Do
You will use ChatGPT, Claude, Perplexity and other AI and research tools to continuously interrogate the pharmaceutical, biotechnology, medical-device and digital-health landscape.
Your work may include:
Identifying deprioritized, discontinued, non-core and capital-stranded therapeutic assets
Finding clinical programs where a failed endpoint may conceal a different development opportunity
Tracking pipeline restructurings, layoffs, strategic reviews and portfolio-prioritization decisions
Identifying assets available for licensing, divestiture or alternative financing
Finding returned rights following terminated pharmaceutical partnerships
Monitoring clinical-trial results, FDA and EMA developments, SEC filings, earnings calls and scientific publications
Identifying biotechnology companies approaching critical financing or strategic inflection points
Researching potential acquisition, licensing, Build-to-Buy and asset-separation opportunities
Mapping potential buyers, sellers, licensors, licensees and strategic partners
Identifying the executives actually responsible for each opportunity
Verifying contact information and building highly targeted outreach
Developing concise investment theses explaining why Harrison Hayes should investigate an opportunity now
Using AI to uncover connections between scientific evidence, corporate strategy, capital constraints and transaction potential that may not be obvious from conventional screening
You will not simply create lists.
You will be expected to answer the harder question:
Why is this an opportunity?
The Work Gets Interesting Quickly
A biotech company announces that it is discontinuing a Phase II program.
Most people record that the drug failed.
We want you to ask:
Did the drug fail, or did the trial fail?
Was the endpoint wrong? Was the population too broad? Is there a responder phenotype buried in the data? Did the program simply fail to clear the company's internal capital-allocation hurdle? Is the underlying biology still credible? Could another indication work? Could the asset be separated from the company? Would another owner develop it differently? What additional experiment would materially change its value?
Those questions can lead to very different conclusions.
Sometimes the answer will be do nothing.
Sometimes it may be license it, acquire it, reposition it, finance it, separate it or build a new company around it.
Finding that distinction is the job.
AI Is the Tool. Judgment Is the Skill.
We are not looking for someone who describes themselves as an “AI expert” because they know how to prompt ChatGPT.
We want someone who understands that AI can be wrong.
You should know how to push beyond the first answer, interrogate primary sources, cross-reference SEC filings and clinical-trial databases, find contradictory evidence, distinguish published facts from inference and recognize when an apparently exciting opportunity falls apart under scrutiny.
A hallucinated executive, invented email address or nonexistent clinical program isn't research. It is a mistake.
We want someone who understands the difference.
Who We're Looking For
Your academic background could be biotechnology, biology, medicine, pharmacology, finance, economics, business, data science or something less obvious.
Graduate students, MBA candidates, medical students and advanced undergraduates are all potentially interesting.
More important is how you think.
You should be intensely curious about science and business simultaneously. You should enjoy discovering obscure information, connecting unrelated facts and pursuing questions that don't have obvious answers.
If you see:
“Company reduces workforce 40% and prioritizes three clinical programs”
your immediate reaction should be:
“What happened to everything else?”
If you read:
“Phase II trial misses primary endpoint but demonstrates statistically significant activity in a prespecified subgroup”
you should want to know:
“Which subgroup, why, and does anyone else care?”
If a pharmaceutical company returns the rights to an asset after spending $100 million developing it, you should wonder:
“What do they know, what does the biotech know, and what might everybody be overlooking?”
That's the mentality we're looking for.
You Will Work With Real Opportunities
This is not an academic exercise.
Interesting findings can move directly into Harrison Hayes' corporate-development process and potentially become strategic advisory, licensing, M&A or principal-investment opportunities.
Harrison Hayes already operates across asset identification, screening, licensing, M&A, strategic advisory, commercial diligence and portfolio strategy.
The extern/intern will help us explore how far AI can extend that capability.
The larger question behind the position is:
Can we build an intelligence system that identifies scientific and transactional opportunities before they become conventional investment-banking opportunities?
We think we can.
We're looking for someone who wants to help prove it.
To Apply
Send your résumé along with a brief note explaining how you use AI for serious research.
But there is a better way to get our attention.
Find us an opportunity.
Identify one pharmaceutical, biotechnology, medical-device or digital-health asset that you believe Harrison Hayes should be looking at right now.
Tell us what happened, why the obvious interpretation may be incomplete, who owns the asset, what you would investigate next, and why there might be a transaction hiding inside the situation.
Keep it to one page.
If it's something we haven't already found, you'll have our attention. Summary
We are seeking a motivated and dynamic AI Corporate Development Extern / Intern to join our innovative team. This role offers a unique opportunity to gain hands-on experience in strategic corporate initiatives, mergers and acquisitions, financial analysis, and stakeholder management within the fast-evolving artificial intelligence industry. As an integral part of our corporate development efforts, you will contribute to evaluating potential growth opportunities, supporting transaction processes, and assisting with strategic planning activities. This paid internship is designed for individuals eager to develop their expertise in finance, strategic management, and AI-driven business expansion while working alongside seasoned professionals.
Responsibilities
- Assist in conducting quantitative financial analysis and valuation modeling to evaluate potential mergers, acquisitions, or strategic partnerships.
- Support the development of financial projection models and cash flow analyses to inform decision-making processes.
- Contribute to due diligence activities related to M&A transactions, including reviewing financial statements and preparing reports.
- Participate in stakeholder management by preparing presentations and communicating insights effectively with executive teams.
- Aid in strategic planning initiatives by analyzing market trends, competitive landscapes, and industry benchmarks.
- Collaborate with cross-functional teams on project management tasks related to corporate finance activities.
- Help prepare documentation for internal audits, technical accounting reviews, and compliance requirements.
Skills
- Strong foundation in financial statement preparation, accounting principles (GAAP), and technical accounting concepts.
- Proficiency in financial modeling, valuation modeling, and developing financial projection models.
- Experience with M&A financial due diligence, investment banking processes, and private equity transactions.
- Excellent verbal communication skills for presenting complex analyses clearly to executives and stakeholders.
- Ability to manage multiple projects efficiently with strong organizational and project management skills.
- Knowledge of financial software tools and presentation software such as PowerPoint or similar platforms.
- Demonstrated understanding of corporate finance concepts including budgeting, forecasting, cash flow analysis, and internal audits.
- Familiarity with quantitative analysis techniques used in equity research and strategic management contexts.
This internship provides an exceptional platform for aspiring finance professionals interested in AI-driven corporate growth strategies. Join us to develop your skills in a fast-paced environment where innovation meets strategic execution!
Work Location: Remote
Corporate Development Analyst Jobs by Experience Level
Top Cities Hiring Corporate Development Analysts
Explore corporate development analyst openings in the cities hiring most right now.
See All 311+ Corporate Development Analyst Jobs
Find roles that match your experience and apply in just a few clicks.
Find JobsCorporate Development Analyst Job Market
Who's Hiring
- Thermo Fisher Scientific20
- JPMorganChase9
- Amazon7
- PNC Financial Services7
- Botrista5
Top Industries Hiring
- Technology & Software17
- Chemicals & Materials5
- Manufacturing4
- Electronics & Hardware4
- Banking & Financial Services4
What Employers Look For
The qualifications that appear most often in corporate development analyst jobs.
- Bachelor's degree in finance, accounting, economics, or a related business field
- Proficiency in financial modeling, valuation, and DCF analysis in Excel
- Experience supporting or executing mergers, acquisitions, or strategic partnerships
- Strong presentation skills with the ability to build and deliver board-level materials
- Familiarity with data rooms, due diligence processes, and transaction documentation
- CFA candidacy or completion is preferred at mid-level and senior analyst roles
Tips for Your Corporate Development Analyst Job Search
Quantify your deal experience precisely
List the transaction sizes, deal counts, and outcomes you contributed to on your resume. Hiring managers in corporate development scan for tangible evidence of M&A or strategic partnership work, so vague phrases like 'supported transactions' won't move your application forward.
Tailor your modeling samples to each company
Bring a version of your financial model that reflects the target company's industry, whether that's a healthcare DCF or a SaaS revenue build. Generic models signal you haven't researched the business, which is a fast disqualifier at the analyst stage.
Apply early to roles that fit
Migrate Mate lists corporate development analyst openings from across the United States in one place, so you can find roles that match and apply directly to each listing.
Filter by deal type not just job title
Search for openings that name your preferred deal type, such as buy-side M&A, venture investments, or integration management, rather than applying to every analyst title. Roles with mismatched deal scope are harder to grow in and tougher to exit from.
Prepare a thesis on the company's next acquisition
Before your interview, draft a one-page view on a logical acquisition target for the company, including strategic rationale and rough valuation. Candidates who walk in with a defensible thesis consistently stand out against those who only discuss past experience.
Negotiate your deal flow access upfront
During the offer stage, ask directly how many live transactions analysts are staffed on per year and whether you'll have client or counterparty exposure. Deal access varies widely across corporate development teams and shapes your long-term exit options significantly.
Corporate Development Analyst Jobs: Frequently Asked Questions
Which companies are hiring the most corporate development analysts?
The companies hiring the most corporate development analysts right now include Thermo Fisher Scientific, JPMorganChase, and Amazon, with the largest share of openings in California, New York, and Massachusetts, based on current listings on Migrate Mate as of September 2026. Demand tends to be highest at large strategics actively pursuing inorganic growth and at private equity-backed platforms in consolidation mode.
How many corporate development analyst jobs are remote?
About 62% of corporate development analyst openings are fully remote or hybrid as of September 2026, reflecting the deal-intensive, relationship-driven nature of the role. Sub-functions focused on market research, competitive intelligence, and financial modeling carry the highest share of remote flexibility compared to integration management or deal execution roles.
How do you become a corporate development analyst?
Most corporate development analysts start in investment banking, management consulting, or corporate finance before moving into a dedicated M&A or strategy team. Building strong financial modeling skills, gaining exposure to due diligence or transaction support, and developing a working knowledge of deal structuring are the clearest preparation steps. Networking directly with corporate development teams at target companies accelerates the transition meaningfully.
Can you get a corporate development analyst job with little experience?
Entry-level corporate development analyst roles exist, but they typically require demonstrated financial modeling ability and some deal exposure, even if informal. Internships in investment banking, private equity, or strategic finance are the most common entry points. Building a deal case study or acquisition thesis for a company you're targeting can substitute for direct deal experience when your resume is otherwise thin.
What does the corporate development analyst interview process look like?
The process typically runs three to four rounds and includes a resume screen, a phone interview covering your deal background, and at least one technical round with a live or take-home modeling exercise. Final rounds often include a case study where you present an acquisition recommendation to senior leadership. Cultural fit and strategic thinking are weighted as heavily as technical accuracy at most companies.
Where can I find and apply to corporate development analyst jobs?
You can find and apply to corporate development analyst jobs on Migrate Mate, which lists current openings from across the United States in one place. Search the listings for roles that match your experience and deal focus, then apply directly to each one that fits.
See All 311+ Corporate Development Analyst Jobs
Find roles that match your experience and apply in just a few clicks.
Find Jobs